Showing results (1-10 of 88) with videos related to
Sort By:
Pageof 9
Frontiers in Pharmacology|October 7, 2015
Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disordersEduardo R Butelman, Mary Jeanne KreekFrontiers in Pharmacology|December 10, 2015
Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disordersEduardo R Butelman, Mary Jeanne KreekExpert Opinion on Emerging Drugs|October 24, 2017
Medications for substance use disorders (SUD): emerging approachesEduardo R Butelman, Mary Jeanne KreekCurrent Topics in Behavioral Neurosciences|May 27, 2016
Discriminative Stimulus Properties of Opioid Ligands: Progress and Future DirectionsEduardo R Butelman, Mary Jeanne KreekNeuropsychiatric Disease and Treatment|May 2, 2018
Gender-specific association of functional <i>prodynorphin</i> 68 bp repeats with cannabis exposure in an African American cohortVadim Yuferov, Eduardo R Butelman, Mary Jeanne KreekTrends in Neurosciences|June 20, 2012
κ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addictionEduardo R Butelman, Vadim Yuferov, Mary Jeanne KreekPsychopharmacology|December 12, 2023
Effect of prenatal and early post-natal oxycodone exposure on the reinforcing and antinociceptive effects of oxycodone in adult C57BL/6 J miceYong Zhang, Eduardo R Butelman, Mary Jeanne KreekFrontiers in Pharmacology|December 9, 2021
Rapid-Onset Anti-Stress Effects of a Kappa-Opioid Receptor Antagonist, LY2795050, Against Immobility in an Open Space Swim Paradigm in Male and Female MiceCaroline Baynard, Thomas E Prisinzano, Eduardo R ButelmanHandbook of Experimental Pharmacology|November 11, 2020
Kappa Opioid Receptor Antagonists as Potential Therapeutics for Mood and Substance Use DisordersBrian Reed, Eduardo R Butelman, Mary Jeanne KreekPsychopharmacology|May 28, 2017
"Effects of the novel relatively short-acting kappa opioid receptor antagonist LY2444296 in behaviors observed after chronic extended-access cocaine self-administration in rats"Marta Valenza, Eduardo R Butelman, Mary Jeanne KreekPageof 9